Home / Peptides / KLOW and GLOW blends

KLOW and GLOW blends Dosage: What the Evidence Says (2026)

Not FDA-approved

Seller-defined mixes of GHK-Cu, BPC-157, TB-500 (GLOW) plus KPV (KLOW). No human data for any blend.

Also called: KLOW, GLOW, klow peptide, glow peptide

Regulatory status (US)

Not approved, and no regulator defines what "KLOW" or "GLOW" contain. The October 2026 HHS draft policy only covers single-ingredient products, so multi-peptide blends fall outside it.

What it is

Names sellers use for pre-mixed vials. GLOW is usually described as GHK-Cu + BPC-157 + TB-500, and KLOW as the same plus KPV, but amounts and ingredients vary by seller.

Dosage

No established human dose. No FDA label or published dose-finding trial gives a dose for KLOW and GLOW blends. Numbers you see on seller sites or forums are not based on reviewed human studies, so we do not list them.

KLOW and GLOW blends reconstitution calculator

Enter your vial and your prescribed dose to see the units on a U-100 syringe.

–
Concentration–
Per 1 unit (0.01 mL)–
Volume per dose–
Doses per vial–

What human studies show

Safety

Questions

Is KLOW and GLOW blends FDA-approved?
Not approved, and no regulator defines what "KLOW" or "GLOW" contain. The October 2026 HHS draft policy only covers single-ingredient products, so multi-peptide blends fall outside it.
What dose of KLOW and GLOW blends has been studied?
There is no established human dose. No human study of any blend. See each ingredient: GHK-Cu, BPC-157, TB-500 and KPV.
How many units is my KLOW and GLOW blends dose?
Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.

Related

Sermorelin

The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.

BPC-157

15-amino-acid peptide studied mostly in animals. Not approved; no established human dose.

TB-500 (thymosin beta-4)

Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.

GHK-Cu (copper peptide)

Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.

Sources

  1. Venable LLP: HHS announces interim enforcement discretion for certain peptides (Nov 2026)
  2. FDA: 503A bulk drug substance categories (updated May 14, 2026, PDF)
  3. FDA 510(k) K212499: BD insulin syringes for U-100 insulin

Last checked 2026-11-16. How we pick and check sources: methodology.